The causal relationship between blood lipids and muscle atrophy based on Mendelian randomization analysis of two samples

doi:10.12307/2024.417

Abstract

Abstract: BACKGROUND: Osteoporosis is often accompanied by sarcopenia and an increased risk of fractures from falls. Recent studies have indicated a close relationship between lipid metabolism and sarcopenia. Abnormal lipid metabolism may directly impact muscle physiological function and metabolism.
OBJECTIVE: To investigate the relationship between lipid metabolism and sarcopenia and evaluate their causal relationship using Mendelian randomization.
METHODS: Mendelian randomization was used to explore the causal relationship between low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, and muscle mass. Research data from genome-wide association studies were used and a sensitivity analysis was conducted to verify the reliability of the results. Approximate indicators of muscle mass, including trunk lean mass and appendicular lean mass, were used as outcome measures.
RESULTS AND CONCLUSION: The study found a negative correlation of low-density lipoprotein cholesterol and triglycerides with muscle mass, while no correlation was observed between high-density lipoprotein cholesterol and muscle mass. The results of the sensitivity analysis indicated a robust causal relationship. Using Mendelian randomization, this study provides evidence of a causal relationship between low-density lipoprotein cholesterol and triglycerides and muscle mass. This finding deepens our understanding of the effects of lipids on sarcopenia and has important clinical implications for the prevention and treatment of sarcopenia and osteoporosis.

Key words: sarcopenia, osteoporosis, Mendelian randomization, lipid metabolism, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, muscle mass

CLC Number:

Peng Zhihua, Pan Junxi, Feng Qinghui, Tian Tianzhao, Zhang Sheng, Li An, Cai Yingfeng. The causal relationship between blood lipids and muscle atrophy based on Mendelian randomization analysis of two samples[J]. Chinese Journal of Tissue Engineering Research, 2024, 28(23): 3699-3703.

Figures/Tables 6

References

[1] JANSSEN I, SHEPARD DS, KATZMARZYK PT, et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80-85.
[2] GANAPATHY A, NIEVES JW. Nutrition and Sarcopenia-What Do We Know? Nutrients. 2020;12(6):1755.
[3] 郑振泉,荣杰生.肌肉减少症:与年龄相关的肌量流失和功能下降[J]. 中国组织工程研究,2022,26(5): 792-797.
[4] 杜娟,杨玲,黄乙欢,等.肌肉减少症治疗研究进展[J]. 中国老年学杂志,2022, 42(2): 506-511.
[5] KANIS JA, ADACHI JD, COOPER C, et al. Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int. 2013;24(11):2763-2764.
[6] WALSH MC, HUNTER GR, LIVINGSTONE MB. Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int. 2006;17(1):61-67.
[7] 杨玲,杜娟,刘荣雁,等.肌肉减少症病因学研究现状与展望[J]. 中国骨质疏松杂志,2020,26(11):1689-1693.
[8] HIRSCHFELD HP, KINSELLA R, DUQUE G. Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int. 2017;28(10):2781-2790.
[9] VELLA CA, NELSON MC, UNKART JT, et al. Skeletal muscle area and density are associated with lipid and lipoprotein cholesterol levels: The Multi-Ethnic Study of Atherosclerosis. J Clin Lipidol. 2020;14(1):143-153.
[10] DU Y, OH C, NO J. Associations between Sarcopenia and Metabolic Risk Factors: A Systematic Review and Meta-Analysis. J Obes Metab Syndr. 2018;27(3):175-185.
[11] BOEF AG, DEKKERS OM, LE CESSIE S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44(2): 496-511.
[12] LAWLOR DA, HARBORD RM, STERNE JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133-1163.
[13] ZHENG J, BAIRD D, BORGES MC, et al. Recent Developments in Mendelian Randomization Studies. Curr Epidemiol Rep. 2017;4(4):330-345.
[14] 王玉琢, 沈洪兵. 孟德尔随机化研究应用于因果推断的影响因素及其结果解读面临的挑战[J]. 中华流行病学杂志,2020,41(8):1231-1236.
[15] HOWE LJ, NIVARD MG, MORRIS TT, et al. Within-sibship genome-wide association analyses decrease bias in estimates of direct genetic effects. Nat Genet. 2022; 54(5):581-592.
[16] SUDLOW C, GALLACHER J, ALLEN N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.
[17] BUCKINX F, LANDI F, CESARI M, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018;9(2):269-278.
[18] ZILLIKENS MC, DEMISSIE S, HSU YH, et al. Large meta-analysis of genome-wide association studies identifies five loci for lean body mass. Nat Commun. 2017; 8(1):80.
[19] LIU HM, ZHANG Q, SHEN WD, et al. Sarcopenia-related traits and coronary artery disease: a bi-directional Mendelian randomization study. Aging (Albany NY). 2020; 12(4):3340-3353.
[20] EVANS DM, DAVEY SMITH G. Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. Annu Rev Genomics Hum Genet. 2015; 16:327-350.
[21] DIDELEZ V, SHEEHAN N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16(4):309-330.
[22] BOWDEN J, DEL GRECO MF, MINELLI C, et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961-1974.
[23] BOWDEN J, DAVEY SMITH G, HAYCOCK PC, et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016;40(4):304-314.
[24] BURGESS S, DUDBRIDGE F, THOMPSON SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35(11):1880-1906.
[25] HEMANI G, ZHENG J, ELSWORTH B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.
[26] DWIPA L, HIDAYAT S, PERMADI SE, et al. Association of Appendicular Skeletal Muscle Mass and Central Obesity Parameters with Lipid Profiles in Older Women. J Med Sci. 2021;9(B):921-924.
[27] BAEK SJ, NAM GE, HAN KD, et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008-2010 Korea National Health and Nutrition Examination Survey. J Endocrinol Invest. 2014; 37(3):247-260.
[28] LENT-SCHOCHET D, JIALAL I. Biochemistry, Lipoprotein Metabolism StatPearls [Internet]. StatPearls Publishing. 2022.
[29] YING Z, TRAMPER N, ZHOU E, et al. Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans. Cardiovasc Res. 2023;119(4):905-918.
[30] WONDMKUN YT. Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications. Diabetes Metab Syndr Obes. 2020;13:3611-3616.
[31] JI Y, LI M, CHANG M, et al. Inflammation: Roles in Skeletal Muscle Atrophy. Antioxidants (Basel). 2022;11(9):1686.
[32] HAMRICK MW. The skeletal muscle secretome: an emerging player in muscle-bone crosstalk. Bonekey Rep. 2012;1:60.
[33] LI CW, YU K, SHYH-CHANG N, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022;13(2):781-794.
[34] SHAH VO, SCARIANO J, WATERS D, et al. Mitochondrial DNA deletion and sarcopenia. Genet Med. 2009;11(3):147-152.
[35] AGUIRRE GA, DE ITA JR, DE LA GARZA RG, et al. Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med. 2016;14:3.
[36] LI Z, XU K, GUO Y, et al. A high-fat diet reverses metabolic disorders and premature aging by modulating insulin and IGF1 signaling in SIRT6 knockout mice. Aging Cell. 2020;19(3):e13104.